Maynard Um
-
-
-
-
-
-
-
Charles River Labs (CRL) PT Raised to $300 at Evercore ISI
-
-
-
-
-
-
-
Morgan Stanley favors Charles River Over IQVIA in CRO sector reset
-
-
-
-
-
-
-
Charles River deploys AI-powered digital pathology workflow
-
-
-
-
-
-
-
Charles River Laboratories (CRL) Tops Q4 EPS by 4c ; Offers Guidance
-
-
-
-
-
-
-
Charles River Laboratories SEC probe ends with no enforcement action
-
-
-
-
-
-
-
Barclays Upgrades Charles River Labs (CRL) to Overweight
-
-
-
-
-
-
-
Charles River Laboratories (CRL) and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
-
455,591 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

